News Solid Biosciences acquires AavantiBio, conducts $75 million ... The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a
News NHS cleared to use Novo Nordisk's long-acting growth hormone Novo Nordisk's long-acting injectable Sogroya has been backed for NHS use in young people with growth hormone deficiency.
